Literature DB >> 23887691

Nrf2 activates augmenter of liver regeneration (ALR) via antioxidant response element and links oxidative stress to liver regeneration.

Rania Dayoub1, Arndt Vogel, Jutta Schuett, Madeleine Lupke, Susannah M Spieker, Nadja Kettern, Eberhard Hildt, Michael Melter, Thomas S Weiss.   

Abstract

Liver regeneration can be impaired by permanent oxidative stress and activation of nuclear factor erythroid 2-related factor 2 (Nrf2), known to regulate the cellular antioxidant response, and has been shown to improve the process of liver regeneration. A variety of factors regulate hepatic tissue regeneration, among them augmenter of liver regeneration (ALR), attained great attention as being survival factors for the liver with proproliferative and antiapoptotic properties. Here we determined the Nrf2/antioxidant response element (ARE) regulated expression of ALR and show ALR as a target gene of Nrf2 in vitro and in vivo. The ALR promoter comprises an ARE binding site and, therefore, ALR expression can be induced by ARE-activator tertiary butylhydroquinone (tBHQ) in hepatoma cells and primary human hepatocytes (PHH). Promoter activity and expression of ALR were enhanced after cotransfection of Nrf2 compared with control and dominant negative mutant of Nrf2. Performing partial hepatectomy in livers from Nrf2+/+ mice compared with Nrf2-/- knock-out (KO) mice, we found increased expression of ALR in addition to known antioxidant ARE-regulated genes. Furthermore, we observed increased ALR expression in hepatitis B virus (HBV) compared with hepatitis C virus (HCV) positive hepatoma cells and PHH. Recently, it was demonstrated that HBV infection activates Nrf2 and, now, we add results showing increased ALR expression in liver samples from patients infected with HBV. ALR is regulated by Nrf2, acts as a liver regeneration and antioxidative protein and, therefore, links oxidative stress to hepatic regeneration to ensure survival of damaged cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23887691      PMCID: PMC3769531          DOI: 10.2119/molmed.2013.00027

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  49 in total

1.  Foxa2 (HNF-3beta) regulates expression of hepatotrophic factor ALR in liver cells.

Authors:  Rania Dayoub; Peter Groitl; Thomas Dobner; Anja Katrin Bosserhoff; Hans-Jürgen Schlitt; Thomas S Weiss
Journal:  Biochem Biophys Res Commun       Date:  2010-04-09       Impact factor: 3.575

2.  Stimulation of the mitogen-activated protein kinase cascade and tyrosine phosphorylation of the epidermal growth factor receptor by hepatopoietin.

Authors:  Y Li; M Li; G Xing; Z Hu; Q Wang; C Dong; H Wei; G Fan; J Chen; X Yang; S Zhao; H Chen; K Guan; C Wu; C Zhang; F He
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

3.  Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins.

Authors:  Monica Carvajal-Yepes; Kiyoshi Himmelsbach; Stephanie Schaedler; Daniela Ploen; Janis Krause; Leopold Ludwig; Thomas Weiss; Karin Klingel; Eberhard Hildt
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

4.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.

Authors:  K Itoh; T Chiba; S Takahashi; T Ishii; K Igarashi; Y Katoh; T Oyake; N Hayashi; K Satoh; I Hatayama; M Yamamoto; Y Nabeshima
Journal:  Biochem Biophys Res Commun       Date:  1997-07-18       Impact factor: 3.575

Review 5.  Apoptosis and necrosis in the liver: a tale of two deaths?

Authors:  Harmeet Malhi; Gregory J Gores; John J Lemasters
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

6.  The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis.

Authors:  Weihua Xu; Claus Hellerbrand; Ulrike A Köhler; Philippe Bugnon; Yuet-Wai Kan; Sabine Werner; Tobias A Beyer
Journal:  Lab Invest       Date:  2008-08-04       Impact factor: 5.662

Review 7.  Nrf2 signaling in coordinated activation of antioxidant gene expression.

Authors:  Anil K Jaiswal
Journal:  Free Radic Biol Med       Date:  2004-05-15       Impact factor: 7.376

8.  Protective effect of augmenter of liver regeneration on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells.

Authors:  Lorenzo Polimeno; Barbara Pesetti; Thomas Lisowsky; Florenzo Iannone; Leonardo Resta; Floriana Giorgio; Rosanna Mallamaci; Maura Buttiglione; Daniela Santovito; Francesco Vitiello; M Elisabetta Mancini; Antonio Francavilla
Journal:  Free Radic Res       Date:  2009-07-23

9.  Hepatic stimulator substance administration ameliorates liver regeneration in an animal model of fulminant hepatic failure and encephalopathy.

Authors:  Alexandra P Margeli; Lila Papadimitriou; Sotirios Ninos; Evangelos Manolis; Michael G Mykoniatis; Stamatios E Theocharis
Journal:  Liver Int       Date:  2003-06       Impact factor: 5.828

10.  New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication.

Authors:  K Himmelsbach; D Sauter; T F Baumert; L Ludwig; H E Blum; E Hildt
Journal:  Gut       Date:  2009-08-25       Impact factor: 23.059

View more
  30 in total

Review 1.  Role of Nrf2 in chronic liver disease.

Authors:  Wei Tang; Yong-Fang Jiang; Murugavel Ponnusamy; Mamadou Diallo
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  Nrf2 is essential for timely M phase entry of replicating hepatocytes during liver regeneration.

Authors:  Yuhong Zou; Min Hu; Joonyong Lee; Shashank Manohar Nambiar; Veronica Garcia; Qi Bao; Jefferson Y Chan; Guoli Dai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-18       Impact factor: 4.052

3.  Tert-Butylhydroquinone alleviates insulin resistance and liver steatosis in diabetes.

Authors:  Tian-Tian Zhu; Chao-Nan Zhu; Ning Huang; Xin Yu; Guang-Rui Wan; Shuang-Xi Wang; Ping Song; Jian Xu; Peng Li; Ya-Ling Yin
Journal:  Indian J Pharmacol       Date:  2022 Mar-Apr       Impact factor: 2.833

4.  Cap-n-Collar Promotes Tissue Regeneration by Regulating ROS and JNK Signaling in the Drosophila melanogaster Wing Imaginal Disc.

Authors:  Amanda R Brock; Mabel Seto; Rachel K Smith-Bolton
Journal:  Genetics       Date:  2017-05-16       Impact factor: 4.562

5.  Wuzhi tablet (Schisandra Sphenanthera extract) protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of NRF2-ARE and p53/p21 pathways.

Authors:  Xiaomei Fan; Yiming Jiang; Ying Wang; Huasen Tan; Hang Zeng; Yongtao Wang; Pan Chen; Aijuan Qu; Frank J Gonzalez; Min Huang; Huichang Bi
Journal:  Drug Metab Dispos       Date:  2014-09-12       Impact factor: 3.922

6.  Involvement of hepatic stimulator substance in the regulation of hepatoblast maturation into hepatocytes in vitro.

Authors:  Guang-Yong Sun; Ling-Yue Dong; Wei An
Journal:  Stem Cells Dev       Date:  2014-05-02       Impact factor: 3.272

Review 7.  Cerium Oxide Nanoparticles: A New Therapeutic Tool in Liver Diseases.

Authors:  Gregori Casals; Meritxell Perramón; Eudald Casals; Irene Portolés; Guillermo Fernández-Varo; Manuel Morales-Ruiz; Victor Puntes; Wladimiro Jiménez
Journal:  Antioxidants (Basel)       Date:  2021-04-24

Review 8.  The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism.

Authors:  Sílvia S Chambel; Andreia Santos-Gonçalves; Tiago L Duarte
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

Review 9.  What is Known Regarding the Participation of Factor Nrf-2 in Liver Regeneration?

Authors:  José A Morales-González; Eduardo Madrigal-Santillán; Ángel Morales-González; Mirandeli Bautista; Evila Gayosso-Islas; Cecilia Sánchez-Moreno
Journal:  Cells       Date:  2015-05-20       Impact factor: 6.600

10.  Maotai ameliorates diethylnitrosamine-initiated hepatocellular carcinoma formation in mice.

Authors:  Xu Yi; Li Long; Chunzhang Yang; Yingying Lu; Mingliang Cheng
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.